These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20340055)

  • 1. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
    Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
    Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
    J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
    Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.
    Shkeir O; Athanassiou-Papaefthymiou M; Lapadatescu M; Papagerakis P; Czerwinski MJ; Bradford CR; Carey TE; Prince ME; Wolf GT; Papagerakis S
    Head Neck; 2013 Nov; 35(11):1542-50. PubMed ID: 23322448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
    Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
    Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck.
    Flowers SA; Zhou X; Wu J; Wang Y; Makambi K; Kallakury BV; Singer MS; Rosen SD; Davidson B; Goldman R
    Oncotarget; 2016 Jul; 7(28):43177-43187. PubMed ID: 27223083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels].
    Karcher J; Reisser C; Daniel V; Herold-Mende C
    HNO; 1999 Oct; 47(10):879-84. PubMed ID: 10550371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma.
    Rashleigh SP; Kusher DI; Endicott JN; Rossi AR; Djeu JY
    Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):541-7. PubMed ID: 8615973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
    Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
    Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
    Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
    Lathers DM; Achille NJ; Young MR
    Hum Immunol; 2003 Dec; 64(12):1160-6. PubMed ID: 14630398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
    Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
    Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
    Bhattacharjee A; Giri S; Roy M; Chakraborty A
    J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
    Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
    Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma.
    Sparano A; Lathers DM; Achille N; Petruzzelli GJ; Young MR
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):573-6. PubMed ID: 15523428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.